First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Hematology Oncology Clinic at Medical West
Birmingham, Alabama, United States
- Northwestern University, Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- Cancer Care Center of Southern Indiana
Bloomington, Indiana, United States
- Iu Health Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Metro Health Cancer Care
Wyoming, Michigan, United States
- Nebraska Cancer Specialists
Omaha, Nebraska, United States
- Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center
New York, New York, United States
- Musc Hollings Cancer Center
Charleston, South Carolina, United States
- University of Texas Medical Branch
Galveston, Texas, United States
- Virginia Oncology Associates
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 24 Apr 2017
- Completion
- 24 Apr 2018
- Last update posted
- 24 Nov 2023
- Registered enrollment
- 36
- Registry id
- NCT01215136
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.